Healthcare Services

Bleeding disorder testing market forecast (2026–2030) with long-term outlook

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Bleeding Disorder Testing Market Expected To Reach Based On Its 2026 Value?

The bleeding disorder testing market size has experienced significant growth in recent years. It is forecast to grow from $16.18 billion in 2025 to $17.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. This historical expansion can be attributed to the increasing prevalence of inherited bleeding disorders, the wider adoption of laboratory diagnostics, the availability of coagulation analyzers, the growth of hospital diagnostic services, and rising clinical awareness of bleeding disorders.

The bleeding disorder testing market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $23.54 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This anticipated growth can be linked to factors such as the heightened need for rapid diagnostic solutions, the broader implementation of personalized medicine approaches, increased capital allocation towards diagnostic automation, the escalating uptake of point-of-care testing, and the incorporation of AI-driven diagnostic analytics. Key developments anticipated during this timeframe involve advancements in coagulation testing accuracy, the increased deployment of point-of-care diagnostic devices, a rising adoption of automated blood analyzers, the widening scope of genetic testing for bleeding disorders, and enhanced integration of digital lab systems.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

What Key Factors Are Affecting The Bleeding Disorder Testing Market Demand?

A rising volume of clinical trials is anticipated to drive expansion in the bleeding disorder testing market in the future. These trials are research endeavors evaluating the safety and effectiveness of new medical interventions, therapies, drugs, or technologies in human subjects. This surge in clinical trials stems from progress in medical research, increased funding for healthcare innovation, and a greater need for novel treatments and therapies. Within clinical trials, bleeding disorder testing serves to evaluate the effectiveness and safety of emerging medications and treatments for bleeding disorders, determine how effectively these interventions manage or rectify clotting issues, and observe patient reactions to guarantee proper dosing and efficacy. For example, data from ClinicalTrials.gov, a US-based registry for clinical trials, indicates that approximately 477,228 trials were registered by the close of 2023, representing an uptick from 437,507 in 2022. Consequently, the growing count of clinical trials is fueling the expansion of the bleeding disorder testing market.

How Is The Bleeding Disorder Testing Market Organized By Segment Classification?

The bleeding disorder testing market covered in this report is segmented –

1) By Product Type: Reagents And Consumables, Instruments

2) By Indication: Hemophilia A, Hemophilia B, Von Willebrand Disease, Idiopathic Thrombocytopenic Purpura, Other Indications

3) By End User: Hospitals And Clinics, Diagnostic Centers, Other End Users

Subsegments:

1) By Reagents And Consumables: Coagulation Reagents, Plasma And Blood Collection Consumables, Hemostasis Reagents, Factor Deficiency Assay Kits, Activated Partial Thromboplastin Time (APTT) Reagents

2) By Instruments: Coagulation Analyzers, Platelet Function Analyzers, Hemostasis Testing Instruments, Point-Of-Care Testing Devices, Automated Blood Testing Systems

What Trends Are Influencing Changes In The Bleeding Disorder Testing Market?

Leading companies in the bleeding disorder testing market are concentrating on creating advanced products, such as gene therapy for Hemophilia B, to deliver enduring solutions, remedy genetic bleeding disorders, improve treatment results, and broaden their market presence. Hemophilia B, a bleeding disorder, is characterized by a lack of clotting factor IX, which is vital for proper blood coagulation. Gene therapy for Hemophilia B presents an upcoming treatment designed to offer a lasting solution by targeting the underlying genetic flaw responsible for the condition. For example, in February 2023, CSL Limited, an Australia-based biotechnology company, along with the European Commission, granted conditional marketing authorization (CMA) for HEMGENIX, which is the inaugural and sole one-time gene therapy for treating severe and moderately severe hemophilia B. This singular treatment aims to provide sustained effectiveness, thereby diminishing or eradicating the necessity for routine factor replacement therapy. HEMGENIX is notable due to its pioneering gene therapy approach, providing a revolutionary choice for patients with hemophilia B and potentially altering the current standard of care within the field.

Who Are The Industry Participants Involved In The Bleeding Disorder Testing Market?

Major companies operating in the bleeding disorder testing market are Siemens Healthineers AG, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Sysmex Corporation, Diagnostica Stago, Werfen Group, Sekisui Chemical Co. Ltd., Helena Laboratories, HORIBA Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Haemonetics Corporation, QuidelOrtho Corporation, Instrumentation Laboratory, Beckman Coulter Inc., Grifols S.A., Meridian Bioscience Inc.

Get The Full Bleeding Disorder Testing Market Report:

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

Which Region Has The Greatest Market Share In The Bleeding Disorder Testing Market?

North America was the largest region in the bleeding disorder testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bleeding Disorder Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report

Browse Through More Reports Similar to the Global Bleeding Disorder Testing Market 2026, By The Business Research Company

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Bleeding Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Blood Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795